KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 46 filers reported holding KRYSTAL BIOTECH INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $305,000 | +4.1% | 7,079 | 0.0% | 0.18% | +11.9% |
| Q2 2020 | $293,000 | -4.2% | 7,079 | 0.0% | 0.16% | -17.1% |
| Q1 2020 | $306,000 | -21.9% | 7,079 | 0.0% | 0.19% | +21.4% |
| Q4 2019 | $392,000 | +95.0% | 7,079 | +22.1% | 0.16% | +89.3% |
| Q3 2019 | $201,000 | -13.7% | 5,797 | 0.0% | 0.08% | -14.3% |
| Q2 2019 | $233,000 | +92.6% | 5,797 | +57.3% | 0.10% | +104.2% |
| Q1 2019 | $121,000 | +290.3% | 3,686 | +145.4% | 0.05% | +220.0% |
| Q4 2018 | $31,000 | – | 1,502 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,913,280 | $153,177,197 | 6.65% |
| Frazier Life Sciences Management, L.P. | 945,407 | $75,689,284 | 5.48% |
| S Squared Technology, LLC | 108,215 | $8,663,693 | 5.14% |
| Nicholas Investment Partners, LP | 374,718 | $29,999,923 | 2.28% |
| Avoro Capital Advisors LLC | 1,750,000 | $140,105,000 | 2.08% |
| Artal Group S.A. | 412,082 | $32,991 | 1.96% |
| First Light Asset Management, LLC | 195,980 | $15,690,159 | 1.41% |
| Integral Health Asset Management, LLC | 85,000 | $6,805,100 | 1.37% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $4,883,660 | 1.36% |
| Hood River Capital Management LLC | 447,393 | $35,818,000 | 1.16% |